论文部分内容阅读
自1991～1994年,我们对23例难治性少量咯血患者采用阿托品治疗,效果显著。患者年龄16～68岁,平均42岁。其中浸润型肺结核并咯血16例,支气管扩张并咯血5例,肺癌并咯血2例。在给予抗结核、抗炎、抗癌及止血对症治疗的同时,均用3种以上止血药物治疗,其中8例治疗3～14天咯血停止,但仍咯血痰;7例间断少量咯血超过2周;1例间断大咯血2次,每次500～700ml,痰中带血时间超过3周;2例痰中带血50余天。
From 1991 to 1994, we treated 23 patients with a small amount of refractory hemoptysis with atropine, the effect is significant. Patients aged 16 to 68 years, mean 42 years old. Including pulmonary tuberculosis and hemoptysis in 16 cases, 5 cases of bronchiectasis and hemoptysis, lung cancer and hemoptysis in 2 cases. In the given anti-TB, anti-inflammatory, anti-cancer and hemostasis symptomatic treatment, are treated with three or more hemostatic drugs, of which 8 cases of treatment for 3 to 14 days to stop hemoptysis, but still hemoptysis; intermittent small hemoptysis more than 2 weeks ; 1 case of intermittent hemoptysis 2 times, each 500 ~ 700ml, bloody sputum more than 3 weeks; 2 cases of bloody sputum more than 50 days.